ProCE Banner Activity

A Discussion of the Rapidly Evolving Landscape in Endometrial Cancer: Addressing Clinical Changes, Challenges, and Disparities


Slides from Ramez N. Eskander, MD, and Shannon N. Westin, MD, MPH, FASCO, covering the recent developments in the rapidly evolving landscape in endometrial cancer, including the use of molecular biomarkers to inform therapy, SGO 2024 clinical trial updates for immunotherapy with or without PARP inhibitors plus chemotherapy, and experts’ strategies for equitable integration of novel therapies into daily practice.

Released: April 09, 2024

Expiration: April 08, 2025



Ramez N. Eskander

Ramez N. Eskander, MD

Clinical Professor of Gynecologic Oncology
Clinical Trials Office Director for Oncology at UC San Diego Health and Moores Cancer Center
Co-Director, UC San Diego Health International Patient Program
Fellowship Director, Gynecologic Oncology
Member of the GOG Foundation
Associate Clinical Trial Advisor, GOG Partners
San Diego, California

Shannon N. Westin

Shannon N. Westin, MD, MPH, FASCO

Medical Director, Gynecologic
Oncology Center
Division of Surgery
Department of Gynecologic Oncology and Reproductive Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas

David Scott Miller

David Scott Miller, MD, FACOG, FACS

Medical Director of Gynecologic Oncology
Chair, Cancer Committee
Parkland Health & Hospital System
Amy and Vernon E. Faulconer Distinguished Chair in Medical Science
Direct and Dallas Foundation Chair in Gynecologic Oncology
Professor of Obstetrics and Gynecology
University of Texas Southwestern Medical Center
Dallas, Texas

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from GlaxoSmithKline.